The t(9; 22) chromosomal translocation causes the constitutive activation of a stable tyrosine kinase BCR/ABL, which suppresses apoptosis while inducing the malignant transformation of CML (Stagno et al. 2016). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.